
Sign up to save your podcasts
Or


Last week Teledoc and Livongo, two of the largest telehealth stocks, announced they are merging. The accelerated adoption of telemedicine has pushed their combined market cap from $8 billion to $38 billion in recent months. However, both stocks dropped roughly 20% in the 3 days since the merger announcement.
Was that an overreaction? Is this a buying opportunity? Or does the market know best and anticipate a downside to the merger?
Today on Dumb Money Live we talk to our close friend, investing partner, and favorite medical doctor, Chase Feiger, to better understand the merger and why the market reacted the way it did about these two monster medical-tech companies becoming one.
By Dumb Money4.7
110110 ratings
Last week Teledoc and Livongo, two of the largest telehealth stocks, announced they are merging. The accelerated adoption of telemedicine has pushed their combined market cap from $8 billion to $38 billion in recent months. However, both stocks dropped roughly 20% in the 3 days since the merger announcement.
Was that an overreaction? Is this a buying opportunity? Or does the market know best and anticipate a downside to the merger?
Today on Dumb Money Live we talk to our close friend, investing partner, and favorite medical doctor, Chase Feiger, to better understand the merger and why the market reacted the way it did about these two monster medical-tech companies becoming one.

3,365 Listeners

1,993 Listeners

395 Listeners

1,832 Listeners

2,117 Listeners

357 Listeners

10,008 Listeners

776 Listeners

440 Listeners

135 Listeners

273 Listeners

555 Listeners

473 Listeners

29 Listeners

76 Listeners